UBS's investment in "double quantity" won the championship
In the past two years, foreign investors have been singing more songs than China, among which Bridgewater is the most representative, not only singing more, but also putting them into practice. The second product invested by Qiaoshui (China) was established on September 28th this year, and the custodian is China Merchants Securities (06099). Up to now, the asset management scale of Qiaoshui (China) investment in China is between 654.38 billion yuan and 654.38 billion yuan.
According to the statistics of private placement network, up to now, there are 30 overseas private placement managers in China market, and 85 products have been issued, with total assets under management exceeding 654.38+0 billion yuan. Among them, UBS investment ranks first in the number of products and the scale of assets under management.
2065438+August 2006, UBS completed the investment registration, which is also the first foreign private equity institution in China with public data. Up to now, UBS Investment * * * has issued 16 products, with assets under management ranging from 2 billion yuan to 5 billion yuan, far ahead of other foreign private placements.
Judging from the scale of assets under management, Shengyuan investment is close to UBS investment, with assets under management ranging from 2 billion yuan to 4 billion yuan. Secondly, DeShao Investment, with assets under management ranging from 654.38 billion yuan to 2 billion yuan. In addition, there are 1 6 foreign private placements with assets under management ranging from 1 100 million yuan, and 1 5 foreign private placements with assets under management ranging from1100 million yuan.
Judging from the number of products issued, only UBS Investment and Credit Suisse Investment have issued products above 10, which are 16 and 12 respectively. Shengyuan Investment and Lubomai Investment followed closely, issuing 9 and 8 respectively; Schroeder invested in six products. Up to now, there are still seven foreign private placements that have not yet issued products, namely Shouyi Investment, Baiji Investment, Maidrui Investment, Balcer Plus (Shanghai) Investment, William O 'Neill Investment, Hongshou Investment and Russell Investment. In addition to the above, 18 foreign private placement also issued different quantities of products.
China's market appeal has increased.
In recent years, the development of foreign private equity in China has accelerated to varying degrees, which shows that the attractiveness of China market is increasing.
Hu Bo said that the investment concept, investment and research system, risk control system, international investment vision and advantages in the field of quantitative investment of foreign-funded institutions will have a great impact on the development of private equity industry in China and guide the domestic private equity industry to mature. Domestic private equity institutions should also foster strengths and avoid weaknesses, give full play to their own advantages, learn advanced investment concepts of foreign private equity, and strengthen their competitiveness.
Lin Jiayi, CEO of Xuanjia Finance, also said that the continuous distribution of foreign capital in China stems from the excellent investment value and growth of China enterprises, which are outstanding in major investment markets around the world. The weight of foreign capital in China's asset allocation is still low, and there is still much room for improvement in the future. It is estimated that 400 billion yuan of incremental funds will enter China every year in the future. In addition, after the allocation weight of foreign capital continues to increase, it is expected to change the pricing logic of A shares.
This article is from Securities Daily.